MedPath

Vitamin D and the Influenza Epidemic

Phase 3
Completed
Conditions
Influenza
Interventions
Drug: choleclaciferol
Registration Number
NCT01182870
Lead Sponsor
University of Tromso
Brief Summary

Subjects included in ongoing vitamin d intervention trials were asked by questionnaire if they were ill with influenza during the winter season 2009/2010 to see if vitamin d supplementation prevented flu like disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
569
Inclusion Criteria
  • participant in vitamin D versus placebo study
Exclusion Criteria
  • none

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
cholecalciferolcholeclaciferolcholecalciferol in doses 800-6000 IU per day
placebocholeclaciferolplacebo identical looking as cholecalciferol capsules
Primary Outcome Measures
NameTimeMethod
influenza during the winter season 2009/2010up to 30 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Tromsø

🇳🇴

Tromsø, Norway

© Copyright 2025. All Rights Reserved by MedPath